Riskpilot← Back to searchSign inGet full accessMediplast Sataside Oy
OYActiveY-tunnus 0433201-0C/O Mediplast Fenno Oy Äyritie 12-BManufacture of other textiles n.e.c. · NACE 1399Est. 1981— employeeshttp://www.sataside.fi
Revenue 2021
EUR 0
EBITDA margin
—
+91% vs 2020
Equity ratio
100.0%
Financial strength
Net profit 2021
EUR -13K
-8543% vs 2020
| Revenue | EUR 0 | — |
| EBITDA | EUR -13K | +91% |
| Net profit | EUR -13K | -8543% |
| Total assets | EUR 209K | -11% |
| Equity | EUR 209K | -6% |
| Employees | — | — |
Legal name
Mediplast Sataside Oy
Y-tunnus number
0433201-0
Legal form
Osakeyhtiö
NACE code
1399 · Manufacture of other textiles n.e.c.
Founded
12. marraskuuta 1981
Share capital
EUR 10 640
Employees
—
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Selvitystilan aikana selvitysmies yksin
Company purpose
Yhtiön toimialana on tekstiilituotteiden valmistus, maahantuonti, tukkukauppa ja vähittäismyynti. Toimintaansa varten yhtiö voi omistaa ja hallita kiinteistöjä sekä oikeuksia ja osakkeita muissa yhtiöissä.
Address
C/O Mediplast Fenno Oy Äyritie 12-B
Phone
+35826303830
Website
http://www.sataside.fi
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Revenue | 1 042 | 909 | 247 | 0 |
| Staff expenses | −221 | −147 | −49 | 0 |
| EBITDA | 152 | 126 | −139 | −13 |
| Depreciation & amort. | −1 | −1 | — | — |
| EBIT | 151 | 125 | −139 | −13 |
| Net financials | 1 | 1 | −1 | −0 |
| Profit before tax | 151 | 126 | 0 | −13 |
| Tax | 30 | 25 | −0 | −0 |
| Net profit | 121 | 101 | 0 | −13 |
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Total assets | 958 | 818 | 234 | 209 |
| Equity | 421 | 321 | 222 | 209 |
| Long-term debt | 450 | 450 | — | — |
| Short-term debt | 87 | 46 | 12 | 0 |
| Total debt | 537 | 496 | 12 | 0 |
EBITDA margin
-1257000.0%
This company
15.8%
Market median
-7955796% vs market
20182021
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
20182021
Return on equity
-6.2%
This company
18.4%
Market median
-134% vs market
20182021
Net profit margin
-1291800.0%
This company
8.1%
Market median
-15948248% vs market
20182021
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20182021
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20182021
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via PRH / YTJ · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via PRH / YTJ · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PH Liquidator | Liquidator | 2021 |
| Former (5) | ||
RM | Audit | 2016 – 2023 |
PS Confidential Clerk | Confidential Clerk | 2018 – 2021 |
TI Confidential Clerk | Confidential Clerk | 2018 – 2019 |
MP Confidential Clerk | Confidential Clerk | 2018 – 2021 |
JO Chief Executive Officer | Chief Executive Officer | 2018 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
| Chairperson | 2018 – 2019 | |
| Chairperson | 2019 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Mediplast Sataside Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Riina Maria Vähäpassi | Audit | 0 companies |
| Piia Susanna Kaartinen | Confidential Clerk | 0 companies |
| Per Henric Wendel | Liquidator | 0 companies |
| Tomi Ilmari Virtanen | Confidential Clerk | 0 companies |
| Marjo Pauliina Tynnilä | Confidential Clerk | 0 companies |
| Johan Olof Mårten Bongstorp | Chief Executive Officer | 0 companies |
| Lars-Erik Ingvar Rydell | Chairperson | 0 companies |
| Rolf Ove Stefan Sandin | Chairperson | 0 companies |